Pharmala Biotech Holdings Ratios and Metrics

Market cap in millions CAD. Fiscal year is September - August.

Millions CAD. Fiscal year is Sep - Aug.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Aug '25 Aug 15, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022
Market Capitalization	14	8	19	4
Market Cap Growth	-37.70%	-58.83%	356.35%	-
Enterprise Value	13	7	17	2
Last Close Price	0.14	0.09	0.22	0.05
PS Ratio	34.20	7.53	35.60	53.16
PB Ratio	5.22	3.94	13.69	2.18
P/TBV Ratio	14.99	61.41	-	6.24
EV/Sales Ratio	31.24	7.05	31.56	25.65
Asset Turnover	0.13	0.39	0.22	-
Inventory Turnover	-	0.62	0.65	-
Quick Ratio	1.57	0.69	0.41	2.13
Current Ratio	2.10	1.14	0.69	2.56
Return on Equity (ROE)	-85.96%	-48.95%	-47.41%	-
Return on Assets (ROA)	-36.24%	-13.58%	-17.63%	-
Return on Capital (ROIC)	-49.69%	-21.44%	-25.42%	-
Earnings Yield	-14.16%	-10.56%	-4.12%	-23.75%
FCF Yield	-	-4.12%	-1.79%	-15.14%
Buyback Yield / Dilution	-11.19%	-4.79%	-5.98%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.